Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors

American Journal of Transplantation

Volumn 10, Issue 12, 2010, Pages 2665-2672

  Hashimoto, K ^a   Eghtesad, B ^a   Gunasekaran, G ^a   Fujiki, M ^a   Uso, T D ^a   Quintini, C ^a   Aucejo, F N ^a   Kelly, D M ^a   Winans, C G ^a   Vogt, D P ^a   Parker, B M ^a   Irefin, S A ^a   Miller, C M ^a   Fung, J J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Biliary complication; donation after cardiac death; ischemic type biliary stricture; liver transplantation; thrombolysis; tissue plasminogen activator

Indexed keywords

ALTEPLASE; LACTIC ACID;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BILE DUCT OBSTRUCTION; BLEEDING; BLOOD TRANSFUSION; BODY MASS; CLINICAL ARTICLE; DRUG DOSE REDUCTION; FEMALE; GRAFT FAILURE; HEART DEATH; HEMOCHROMATOSIS; HEPATIC ARTERY; HEPATITIS B; HEPATITIS C; HUMAN; ISCHEMIA; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; REPERFUSION; THROMBOSIS;

ADOLESCENT; ADULT; AGED; BILE DUCTS; CONSTRICTION, PATHOLOGIC; DEATH; FEMALE; GRAFT REJECTION; HUMANS; ISCHEMIA; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 78649816458     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03337.x     Document Type: Article

References (33)

1. Casavilla A, Ramirez C, Shapiro R, et al,. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation 1995; 59: 197-203.
2. Mateo R, Cho Y, Singh G, et al,. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: An analysis of OPTN/UNOS data. Am J Transplant 2006; 6: 791-796.
3. Cameron AM, Ghobrial RM, Yersiz H, et al,. Optimal utilization of donor grafts with extended criteria: A single-center experience in over 1000 liver transplants. Ann Surg 2006; 243: 748-753.
4. Hashimoto K, Miller C,. The use of marginal grafts in liver transplantation. J Hepatobiliary Pancreat Surg 2008; 15: 92-101.
5. Scientific Registry of Transplant Recipients. 2008 OPTN/SRTR Annual Report: Liver and Intestine Transplantation in the United States 1998-2007. Available at:. Accessed February 2010.
6. Merion RM, Pelletier SJ, Goodrich N, Englesbe MJ, Delmonico FL,. Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg 2006; 244: 555-562.
7. Selck FW, Grossman EB, Ratner LE, Renz JF,. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: Implications for further expansion of the deceased-donor pool. Ann Surg 2008; 248: 599-607.
8. Foley DP, Fernandez LA, Leverson G, et al,. Donation after cardiac death: The University of Wisconsin experience with liver transplantation. Ann Surg 2005; 242: 724-731.
9. Muiesan P, Girlanda R, Jassem W, et al,. Single-center experience with liver transplantation from controlled non-heartbeating donors: A viable source of grafts. Ann Surg 2005; 242: 732-738.
10. Fujita S, Mizuno S, Fujikawa T, et al,. Liver transplantation from donation after cardiac death: A single center experience. Transplantation 2007; 84: 46-49.
11. De Vera ME, Lopez-Solis R, Dvorchik I, et al,. Liver transplantation using donation after cardiac death donors: Long-term follow-up from a single center. Am J Transplant 2009; 9: 773-781.
12. Grewal HP, Willingham DL, Nguyen J, et al,. Liver transplantation using controlled donation after cardiac death donors: An analysis of a large single-center experience. Liver Transpl 2009; 15: 1028-1035.
13. Abt P, Crawford M, Desai N, Markmann J, Olthoff K, Shaked A,. Liver transplantation from controlled non-heart-beating donors: An increased incidence of biliary complications. Transplantation 2003; 75: 1659-1663.
14. Maheshwari A, Maley W, Li Z, Thuluvath PJ,. Biliary complications and outcomes of liver transplantation from donors after cardiac death. Liver Transpl 2007; 13: 1645-1653.
15. Chan EY, Olson LC, Kisthard JA, et al,. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl 2008; 14: 604-610.
16. Skaro AI, Jay CL, Baker TB, et al,. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: The untold story. Surgery 2009; 146: 543-552.
17. Ohtani O, Kikuta A, Ohtsuka A, Taguchi T, Murakami T,. Microvasculature as studied by the microvascular corrosion casting/scanning electron microscope method. I. Endocrine and digestive system. Arch Histol Jpn 1983; 46: 1-42.
18. Yamamoto K, Sherman I, Phillips MJ, Fisher MM,. Three dimensional observations of the hepatic arterial terminations in rat, hamster and human liver by scanning electron microscopy of microvascular casts. Hepatology 1985; 5: 452-456.
19. Brott T, Bogousslavsky J,. Treatment of acute ischemic stroke. N Engl J Med 2000; 343: 710-722.
20. Fukuzawa K, Schwartz ME, Acarli K, et al,. Flushing with autologous blood improves intraoperative hemodynamic stability and early graft function in clinical hepatic transplantation. J Am Coll Surg 1994; 178: 541-547.
21. Monbaliu D, Vekemans K, Hoekstra H, et al,. Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity. Ann Surg 2009; 250: 808-817.
22. Fung JJ, Eghtesad B, Patel-Tom K,. Using livers from donation after cardiac death donors-a proposal to protect the true Achilles heel. Liver Transpl 2007; 13: 1633-1636.
23. Reich DJ, Mulligan DC, Abt PL, et al,.; ASTS Standards on Organ Transplantation Committee. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant 2009; 9: 2004-2011.
24. Lee KW, Simpkins CE, Montgomery RA, Locke JE, Segev DL, Maley WR,. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 2006; 82: 1683-1688.
25. Pinna AD, Smith CV, Furukawa H, Starzl TE, Fung JJ,. Urgent revascularization of liver allografts after early hepatic artery thrombosis. Transplantation 1996; 62: 1584-1587.
26. Yamauchi JI, Richter S, Vollmar B, Menger MD, Minor T,. Warm preflush with streptokinase improves microvascular procurement and tissue integrity in liver graft retrieval from non-heart-beating donors. Transplantation 2000; 69: 1780-1784.
27. Minor T, Hachenberg A, Tolba R, Pauleit D, Akbar S,. Fibrinolytic preflush upon liver retrieval from non-heart beating donors to enhance postpreservation viability and energetic recovery upon reperfusion. Transplantation 2001; 71: 1792-1796.
28. Sugimoto R, Date H, Sugimoto S, et al,. Post-mortem administration of urokinase in canine lung transplantation from non-heart-beating donors. J Heart Lung Transplant 2006; 25: 1148-1153.
29. Gok MA, Shenton BK, Buckley PE, et al,. How to improve the quality of kidneys from non-heart-beating donors: A randomised controlled trial of thrombolysis in non-heart-beating donors. Transplantation 2003; 76: 1714-1719.
30. Lee HW, Suh KS, Shin WY, et al,. Classification and prognosis of intrahepatic biliary stricture after liver transplantation. Liver Transpl 2007; 13: 1736-1742.
31. Nakamura N, Nishida S, Neff GR, et al,. Intrahepatic biliary strictures without hepatic artery thrombosis after liver transplantation: An analysis of 1,113 liver transplantations at a single center. Transplantation 2005; 79: 427-432.
32. Hashimoto K, Miller CM, Quintini C, et al,. Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients Surgery 2010; 148: 582-588.
33. Stewart ZA, Cameron AM, Singer AL, Montgomery RA, Segev DL,. Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant 2009; 9: 286-293.